Back to overview

CDA is part of the procekt PHOCNOSIS

Header Phocnosis

The PHOCNOSIS project aims at the development and the preclinical validation of a nanotechnology-based handheld point-of-care testing (POCT) analysis device for its application in the early diagnosis of cardiovascular diseases (CVD). The diagnosis will be carried out by means of the fast (<10 minutes), ultra-sensitive (<1 ng/L) and label-free detection of multiple cardiac biomarkers, using a small volume of whole blood (<100 μL). This POCT analysis device will significantly help in the implementation of mass screening programs, with the consequent impact on clinical management, reducing also costs of treatments, and increasing survival rates.

The project started in September 2015 for a period of 3 year.

More Information under www.phocnosis.eu


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634013

Back to overview

25.05.2016

CDA on www

CDA auf Facebook CDA auf Twitter CDA bei Xing